Extractive Spectrophotometric Determination of Anti-Inflammatory Drug Nimesulide in Pharmaceutical Formulations and Human Plasma

被引:0
作者
Saber, Amr Lotfy [1 ,2 ]
El-Sayed, Gamal Owes [3 ]
机构
[1] Umm Al Qura Univ, KSA, Fac Sci, Dept Chem, Zagazig, Egypt
[2] Zagazig Univ, Zagazig, Egypt
[3] Benha Univ, Fac Sci, Dept Chem, Banha, Egypt
关键词
Nimesulide; extractive spectrophotometry; pharmaceutical; human plasma; PERFORMANCE LIQUID-CHROMATOGRAPHY; VOLTAMMETRIC DETERMINATION; COX-2; INHIBITORS; DOSAGE FORMS; HYDROXYNIMESULIDE;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The goal of the present work is to develop simple, rapid, and sensitive extractive spectrophotometric methods for the assay of nimesulide in pharmaceutical formulations and human plasma. The methods depend on the formation of colored ion-pair complexes between nimesulide and Five different reagents, bromocresol green (BCG), bromocresol purple (BCP), bromothymol blue (BTB), brilliant blue G (BBG) and methyl orange (MO) in Britton-Robinson buffer solutions of pH 2.0 - 3.5. The colored products were extracted in chloroform and absorbance measured at 412, 410, 407, 502 and 482 nm, respectively. The analytical parameters and their effects on the reported systems were investigated. The extracts are intensely colored and very stable at room temperature. The calibration graphs were linear over the concentration range of 2 - 18 mu g/mL for BCG, BTB and BBG, 2 - 16 mu g/mL for BCP and 2 - 14 mu g/mL for MO. The stoichiometry of the reaction was found to be 1 : 1 in all cases and the conditional stability constant (K-f) of the complexes were calculated. The proposed methods were successfully extended to pharmaceutical preparations in tablet form. Excipients used as additives in commercial formulations did not interfere with the analysis. The proposed methods can be recommended for quality control and routine analysis where time, cost effectiveness and high specificity of the analytical technique are of great importance.
引用
收藏
页码:429 / 436
页数:8
相关论文
共 38 条
  • [1] Determination of nimesulide in pharmaceutical dosage forms by second order derivative UV spectrophotometry
    Altinöz, S
    Dursun, ÖÖ
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (01) : 175 - 182
  • [2] BAHRAM H, 2008, J PHARM BIOMED ANAL, V47, P625
  • [3] Quantification of nimesulide in human plasma by high-performance liquid chromatography/tandem mass spectrometry.: Application to bioequivalence studies
    Barrientos-Astigarraga, RE
    Vannuchi, YB
    Sucupira, M
    Moreno, RA
    Muscará, MN
    De Nucci, G
    [J]. JOURNAL OF MASS SPECTROMETRY, 2001, 36 (12): : 1281 - 1286
  • [4] Bennett A, 2000, Expert Opin Pharmacother, V1, P277, DOI 10.1517/14656566.1.2.277
  • [5] BISCARINI L, 1988, Drugs of Today, V24, P23
  • [6] Britton H.T.S., 1952, HYDROGEN IONS, P113
  • [7] Mass spectrometric characterization and HPLC determination of the main urinary metabolites of nimesulide in man
    Carini, M
    Aldini, G
    Stefani, R
    Marinello, C
    Facino, RM
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) : 201 - 211
  • [8] SIMULTANEOUS DETERMINATION OF NIMESULIDE AND HYDROXYNIMESULIDE IN HUMAN-PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    CASTOLDI, D
    MONZANI, V
    TOFANETTI, O
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 425 (02): : 413 - 418
  • [9] NIMESULIDE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY
    DAVIS, R
    BROGDEN, RN
    [J]. DRUGS, 1994, 48 (03) : 431 - 454
  • [10] *EUR DIR QUAL MED, 2002, EUR PHARM